IL1B and lung carcinoma: Taken together, the data suggest that healthy donor PBMCs increase their expression of CCL3, IL8 and IL1β (with little or no increases in CXCL10 and IL2Rα) when they are exposed to lung cancer cells (Figures 4and5).